Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Linzagolix

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Linzagolix

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Kissei Pharmaceutical

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    Looking for 935283-04-8 / Linzagolix API manufacturers, exporters & distributors?

    Linzagolix manufacturers, exporters & distributors 1

    86

    PharmaCompass offers a list of Linzagolix API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linzagolix manufacturer or Linzagolix supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linzagolix manufacturer or Linzagolix supplier.

    API | Excipient name

    Linzagolix

    Synonyms

    935283-04-8, Linzagolix [inn], Linzagolix [usan], Obe-2109, 7cdw97huex, Obe2109

    Cas Number

    935283-04-8

    Unique Ingredient Identifier (UNII)

    7CDW97HUEX

    About Linzagolix

    Linzagolix is an orally bioavailable gonadotropin-releasing hormone (GnRH or LHRH) receptor antagonist, with potential hormone production inhibitory activity. Upon oral administration of linzagolix, this agent competes with GnRH for receptor binding and inhibits GnRH receptor signaling in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with hormonally dependent disease states such as hormone-dependent prostate cancer. In women, this prevents the production of estrogen by the ovaries and may relieve symptoms from sex-hormone dependent diseases, such as pain associated with endometriosis, heavy menstrual bleeding or uterine fibroids.

    Linzagolix Manufacturers

    A Linzagolix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linzagolix, including repackagers and relabelers. The FDA regulates Linzagolix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linzagolix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Linzagolix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

    Linzagolix Suppliers

    A Linzagolix supplier is an individual or a company that provides Linzagolix active pharmaceutical ingredient (API) or Linzagolix finished formulations upon request. The Linzagolix suppliers may include Linzagolix API manufacturers, exporters, distributors and traders.

    click here to find a list of Linzagolix suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

    Linzagolix USDMF

    A Linzagolix DMF (Drug Master File) is a document detailing the whole manufacturing process of Linzagolix active pharmaceutical ingredient (API) in detail. Different forms of Linzagolix DMFs exist exist since differing nations have different regulations, such as Linzagolix USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Linzagolix DMF submitted to regulatory agencies in the US is known as a USDMF. Linzagolix USDMF includes data on Linzagolix's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Linzagolix USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Linzagolix suppliers with USDMF on PharmaCompass.

    Linzagolix Manufacturers | Traders | Suppliers

    Linzagolix Manufacturers, Traders, Suppliers 1
    20

    We have 1 companies offering Linzagolix

    Get in contact with the supplier of your choice:

    1. Kissei Pharmaceutical
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.